Novo Nordisk | NVO - Interest Income


Novo Nordisk reported DKK6.05B in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Aurora Cannabis CAD 1.04M 808K Mar/2026
Bausch Health Companies USD 11M 1000K Jun/2026
Canopy Growth CAD 3.86M 1.89M Mar/2026
Corcept Therapeutics USD 4.89M 537K Mar/2026
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Merck USD 35M 34M Mar/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novo Nordisk DKK 6.05B 2.63B Mar/2026
Pacira USD 1.93M 365K Mar/2026
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 77M 17M Jun/2026
Supernus Pharmaceuticals USD 2.63M 248K Jun/2026
Zoetis USD 21M 4M Mar/2026